Geographic Atrophy

Latest News

FDA grants Breakthrough Therapy Designation for Tinlarebant
FDA grants Breakthrough Therapy Designation for Tinlarebant

May 21st 2025

The designation is based off previously reported phase 3 data from the ongoing DRAGON trial.

Structure-function link between ellipsoid zone integrity features and visual acuity in eyes with GA
Structure-function link between ellipsoid zone integrity features and visual acuity in eyes with GA

May 15th 2025

Baseline status of the central subfield ellipsoid zone predicts future visual loss
Baseline status of the central subfield ellipsoid zone predicts future visual loss

May 14th 2025

Living with GA: How patients in the US and Western Europe cope
Living with GA: How patients in the US and Western Europe cope

May 14th 2025

Video Series
Video Interviews
Podcasts
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
Innovation Series: A stem cell patch for treating advanced dry AMD
Ehsan Sadri, MD,  leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

More News

© 2025 MJH Life Sciences

All rights reserved.